The Particle Therapy Co-Operative Group is a worldwide organisation of scientists and professionals interested in proton, light ion and heavy charged particle radiotherapy. The mission of PTCOG is to promote science, technology and practical clinical application of particle therapy, with the ultimate goal of improving treatment of cancer to the highest possible standards in radiation therapy.
With Manchester's own contribution to the history of particle science, and technological innovation that has continued to this day, we are proud that PTCOG58 will be centred around the theme of innovation - scientific, clinical, technical and industrial - and how the worldwide growth of particle therapy will develop in years to come.
The PTCOG Scientific Committee will bring you the very latest developments in an excellent scientific programme, varied activities both at and away from the conference, and specialist speakers, who are influencers and experts in the field.
Hear the latest research, gain take-away tools to adopt the newest practices and nurture collaborations with the particle therapy international community at PTCOG58 in Manchester.
Online registration opens in November 2018.
The accepted abstract topics at PTCOG58 cover a broad range of issues related to improving treatment of cancer with particle therapy. The topics are divided into 4 categories: Clincal, Physics, Biology and Multidisciplinary.
Abstract submission opens in November 2018.
Speakers: Jay Flanz, Tadashi Kamada, Marco Durante, Eugen Hug, Martin Jermann, Zelig Tochner, Huan Giap, Anita Mahajan, Prof. Ran Mackay, Prof. Karen Kirkby, Dr Ed Smith, James Weightman, Anita Mahajan, Antony Lomax, Marcelo Vazquez